Alnylam issues 2022 corporate responsibility report

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today published its 2022 corporate responsibility report. this year's edition reasserts our commitment to advancing pioneering rnai science and supporting health equity. the company continues to take meaningful steps across each of our six corporate responsibility pillars to ensure everyone has access to essential health services and medicines. as the company further these eff.
ALNY Ratings Summary
ALNY Quant Ranking